AK
Ajay Kumar
Yeungnam University, Institute of Nano Science and Technology, Babasaheb Bhimrao Ambedkar University, Mahatma Jyotiba Phule Rohilkhand University
Employment
-
Yeungnam University Postdoctral Fellow2025 - Present
-
Institute of Nano Science and Technology SRF2020 - Present
-
Institute of Nano Science and Technology JRF2018 - 2020
-
CSIR - Central Institute of Medicinal and Aromatic Plants Project Assistant - II2016 - 2017
Education
-
Babasaheb Bhimrao Ambedkar University M. Pharm2013 - 2015
-
Mahatma Jyotiba Phule Rohilkhand University B. Pharm2009 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (44)
- Zein-Coated Eicosapentaenoic Acid-Based Glibenclamide Nanocarriers for Treating Ulcerative Colitis Save
- Corrigendum to “Sinapic acid-pullulan based inflammation responsive nanomicelles for the local treatment of experimental inflammatory arthritis” [Int. J. Biol. Macromol. 278 (2024) 134903] Save
- Mucin armoured diethylaminoethyl-dextran cloaked rebamipide based oral nanoformulation for the therapy of inflammatory bowel disease Save
- Engineered Drug-Amphiphile Conjugate Nanoparticles for Targeted Inhibition of AQP4-Mediated NLRP3 Inflammasome Signaling in Collagen-Induced Rheumatoid Arthritis Save
- Leveraging thiol-functionalized biomucoadhesive hybrid nanoliposome for local therapy of ulcerative colitis Save
- Beta-Sitosterol-Conjugated Sinapic Acid-Engineered Nanoliposome: Biomucoadhesive and Enzyme-Responsive Targeted Oral Therapy in Ulcerative Colitis Save
- Bioactive chitosan-BSA Maillard-derived chrysin-loaded nanoparticles: A gastroprotective, biomucoadhesive approach for enhanced oral therapy in ulcerative colitis Save
- Multifunctional chrysin-loaded gallic acid–glycerol monostearate conjugate-based injectable hydrogel for targeted inhibition of hypoxia-induced NLRP3 inflammasome in ulcerative colitis Save
- A bioactive and biodegradable vitamin C stearate-based injectable hydrogel alleviates experimental inflammatory arthritis Save
- Therapeutic cargo-free linalool-based nanoparticles attenuate inflammation by targeting NLRP3 inflammasome Save